JIC
WST icon

Johnson Investment Counsel’s West Pharmaceutical WST Stock Holding History

Johnson Investment Counsel’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,738
Closed -$983K – 669
2021
Q2 		$983K Hold
2,738
– – 0.01% 332
2021
Q1 		$772K Sell
2,738
-555
-17% -$159K 0.01% 355
2020
Q4 		$933K Sell
3,293
-22
-0.7% -$6.17K 0.02% 313
2020
Q3 		$911K Sell
3,315
-3,452
-51% -$914K 0.02% 298
2020
Q2 		$1.54M Sell
6,767
-935
-12% -$184K 0.03% 208
2020
Q1 		$1.17M Buy
7,702
+350
+5% +$53.9K 0.03% 222
2019
Q4 		$1.1M Buy
+7,352
New +$1.07M 0.02% 297

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Johnson Investment Counsel's WST Position: Q3 2021 in Review

Johnson Investment Counsel sold out of West Pharmaceutical (WST) in Q3 2021, closing a stake of 2,738 shares — an estimated $983K sold.

Johnson Investment Counsel first reported a position in WST in Q4 2019 and held it in 7 quarters. The position peaked at $1.54M in Q2 2020. 670 funds tracked by Wall St. Rank hold WST as of Q3 2021.

  • Johnson Investment Counsel reported no remaining West Pharmaceutical position as of Q3 2021 after selling out during the quarter.
  • Johnson Investment Counsel sold 2,738 West Pharmaceutical shares in Q3 2021, an estimated $983K.
  • Johnson Investment Counsel first reported a position in West Pharmaceutical in Q4 2019 and held it in 7 quarters.
  • Johnson Investment Counsel's West Pharmaceutical position peaked at $1.54M in Q2 2020.
  • 670 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2021.

Based on Johnson Investment Counsel's 13F filing for Q3 2021, filed 12 Nov 2021.